Peptide for reducing the phosphate requirement and excretion from farm animals
US-9078842-B2 · Jul 14, 2015 · US
FGF-23 epitope peptide for improving resistance to breakage and eggshell strength
US10544197B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10544197-B2 |
| Application number | US-201715675022-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2017 |
| Priority date | Aug 12, 2016 |
| Publication date | Jan 28, 2020 |
| Grant date | Jan 28, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Described herein are FGF-23 epitope peptides, methods of producing antibodies in laying hens by injecting the peptides, and methods of improving resistance to eggshell breakage and/or increasing eggshell strength by administering an FGF-23 epitope peptide to a laying hen.
First claim
Opening claim text (preview).
The invention claimed is: 1. An FGF-23 epitope peptide, wherein the peptide is 8-12 amino acids in length and comprises SEQ ID NO: 3 or SEQ ID NO: 4 and wherein the FGF-23 epitope peptide is conjugated to a carrier protein. 2. The FGF-23 epitope peptide of claim 1 , wherein the carrier protein is bovine gamma globulin, bovine serum albumin, keyhole limpet hemocyanin, or ovalbumin. 3. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and an FGF-23 epitope peptide, wherein the FGF-23 epitope peptide is 8-12 amino acids in length and comprises SEQ ID NO: 3 or SEQ ID NO: 4, and wherein the FGF-23 epitope peptide is conjugated to a carrier protein. 4. The composition of claim 3 , wherein the carrier protein is bovine gamma globulin, bovine serum albumin, keyhole limpet hemocyanin, or ovalbumin. 5. The pharmaceutical composition of claim 3 , wherein the composition is for oral, aerosol, or parenteral administration. 6. The pharmaceutical composition of claim 5 , wherein the pharmaceutically acceptable excipient is an immunological adjuvant.
Assignees
Inventors
Classifications
against growth factors {; against growth regulators} · CPC title
the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines · CPC title
Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL] · CPC title
Vertebrate antigens (from snakes A61K39/38) · CPC title
characterised by the link between antigen and carrier · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10544197B2 cover?
- Described herein are FGF-23 epitope peptides, methods of producing antibodies in laying hens by injecting the peptides, and methods of improving resistance to eggshell breakage and/or increasing eggshell strength by administering an FGF-23 epitope peptide to a laying hen.
- Who is the assignee on this patent?
- Wisconsin Alumni Res Found
- What technology area does this patent fall under?
- Primary CPC classification C07K14/50. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).